ArticleJournal of clinical medicine2025

Switching from Intravenous to Subcutaneous Infliximab in Psoriasis: A Case Series on Efficacy and Treatment Satisfaction.

Daniele Rizzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.